Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX

Toxicology and Applied Pharmacology

Volumn 219, Issue 2-3, 2007, Pages 142-150

  Nambiar, Madhusoodana P ^a,c   Gordon, Richard K ^a   Rezk, Peter E ^a   Katos, Alexander M ^a   Wajda, Nikolai A ^a   Moran, Theodore S ^b   Steele, Keith E ^a   Doctor, Bhupendra P ^a   Sciuto, Alfred M ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b U S ARMY   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Acetylcholinesterase; Chemical warfare nerve agents; Guinea pig; Inhalation exposure; Microinstillation; Organophosphates; Pulmonary injury; Pulmonary therapeutics; Respiratory system

Indexed keywords

ACETYLCYSTEINE; ANTISENSE OLIGONUCLEOTIDE; ATROPINE; ATROPINE METHYL BROMIDE; BERACTANT; CHEMICAL WARFARE AGENT; DEXAMETHASONE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL WARFARE; CONTROLLED STUDY; DRUG EFFICACY; GUINEA PIG; HISTOPATHOLOGY; LUNG LAVAGE; LUNG TOXICITY; LUNG WEIGHT; MALE; NONHUMAN; PROTECTION; SURVIVAL RATE;

ACETYLCYSTEINE; ACUTE DISEASE; ANIMALS; ATROPINE DERIVATIVES; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CHEMICAL WARFARE AGENTS; GUINEA PIGS; INHALATION EXPOSURE; LUNG DISEASES; MALE; ORGAN SIZE; ORGANOTHIOPHOSPHORUS COMPOUNDS; PROTEINS; PULMONARY SURFACTANTS; RESPIRATORY MUCOSA;

ANIMALIA; CAVIA;

EID: 33847119805     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.11.002     Document Type: Article

References (40)

1. Abdel-Rahman A., Shetty A.K., and Abou-Donia M.B. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships. Neuroscience 113 (2002) 721-741
2. Abu-Qare A.W., and Abou-Donia M.B. Sarin: health effects, metabolism, and methods of analysis. Food Chem. Toxicol. 40 (2002) 1327-1333
3. Anthony J.S., Haley M., Manthei J., Way R., Burnett D., Gaviola B., Sommerville D., Crosier R., Mioduszewski R., Thomson S., Crouse C., and Matson K. Inhalation toxicity of cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: potency comparison to sarin (GB). Inhal. Toxicol. 16 (2004) 103-111
4. Anzueto A., Berdine G.G., Moore G.T., Gleiser C., Johnson D., White C.D., and Johanson Jr. W.G. Pathophysiology of soman intoxication in primates. Toxicol. Appl. Pharmacol. 86 (1986) 56-68
5. Anzueto A., deLemos R.A., Seidenfeld J., Moore G., Hamil H., Johnson D., and Jenkinson S.G. Acute inhalation toxicity of soman and sarin in baboons. Fundam. Appl. Toxicol. 14 (1990) 676-687
6. Bajgar J., Sevelova L., Krejcova G., Fusek J., Vachek J., Kassa J., Herink J., de Jong L.P., and Benschop H. Biochemical effects of low level exposure to soman vapour. Cent. Eur. J. Public Health 12 (2004) S4-S7 (Suppl.)
7. Bajgar J., Sevelova L., Krejcova G., Fusek J., Vachek J., Kassa J., Herink J., de Jong L.P., and Benschop H.P. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal. Toxicol. 16 (2004) 497-507
8. Benschop H.P., Trap H.C., Spruit H.E., van der Wiel H.J., Langenberg J.P., and de Jong L.P. Low level nose-only exposure to the nerve agent soman: toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 153 (1998) 179-185
9. Bide R.W., and Risk D.J. Inhalation toxicity in mice exposed to sarin (GB) for 20-720 min. J. Appl. Toxicol. 24 (2004) 459-467
10. Bogucki S., and Weir S. Pulmonary manifestations of intentionally released chemical and biological agents. Clin. Chest Med. 23 (2002) 777-794
11. Buchanan K.C., Burge R.R., and Ruble G.R. Evaluation of injectable anesthetics for major surgical procedures in guinea pigs. Contemp. Top. Lab Anim. Sci. 37 (1998) 58-63
12. Caranto G.R., Waibel K.H., Asher J.M., Larrison R.W., Brecht K.M., Schutz M.B., Raveh L., Ashani Y., Wolfe A.D., and Maxwell D.M. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes. Biochem. Pharmacol. 47 (1994) 347-357
13. Chilcott R.P., Dalton C.H., Hill I., Davidson C.M., Blohm K.L., and Hamilton M.G. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig. Hum. Exp. Toxicol. 22 (2003) 255-261
14. DeLorenzo R.A. Exposed. Signs, symptoms and EMS management of nerve-agent poisoning. JEMS 26 (2001) 48-57
15. Ghanei M., Mokhtari M., Mohammad M.M., and Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur. J. Radiol. 52 (2004) 164-169
16. Graham J.R., Wright B.S., Rezk P.E., Gordon R.K., Sciuto A.M., and Nambiar M.P. Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX. Inhal. Toxicol. 18 (2006) 493-500
17. Greenfield R.A., Brown B.R., Hutchins J.B., Iandolo J.J., Jackson R., Slater L.N., and Bronze M.S. Microbiological, biological, and chemical weapons of warfare and terrorism. Am. J. Med. Sci. 323 (2002) 326-340
18. Hartmann H.M. Evaluation of risk assessment guideline levels for the chemical warfare agents mustard, GB, and VX. Regul. Toxicol. Pharmacol. 35 (2002) 347-356
19. Hyams K.C., Murphy F.M., and Wessely S. Responding to chemical, biological, or nuclear terrorism: the indirect and long-term health effects may present the greatest challenge. J. Health Polit. Policy Law 27 (2002) 273-291
20. Jamal G.A. Long term neurotoxic effects of chemical warfare organophosphate compounds (sarin). Adverse Drug React. Toxicol. Rev. 14 (1995) 83-84
21. Jimmerson V.R., Shih T.M., Maxwell D.M., Kaminskis A., and Mailman R.B. The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat. Fundam. Appl. Toxicol. 13 (1989) 568-575
22. Jimmerson V.R., Shih T.M., Maxwell D.M., and Mailman R.B. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat. Toxicol. Lett. 48 (1989) 93-103
23. Karalliedde L., Wheeler H., Maclehose R., and Murray V. Possible immediate and long-term health effects following exposure to chemical warfare agents. Public Health 114 (2000) 238-248
24. Lainee P., Robineau P., Guittin P., Coq H., and Benchetrit G. Mechanisms of pulmonary edema induced by an organophosphorus compound in anesthetized dogs. Fundam. Appl. Toxicol. 17 (1991) 177-185
25. Leikin J.B., Thomas R.G., Walter F.G., Klein R., and Meislin H.W. A review of nerve agent exposure for the critical care physician. Crit. Care Med. 30 (2002) 2346-2354
26. Levy A., Chapman S., Cohen G., Raveh L., Rabinovitz I., Manistersky E., Kapon Y., Allon N., and Gilat E. Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: comparative efficacy of three oximes. J. Appl. Toxicol. 24 (2004) 501-504
27. Martin T., and Lobert S. Chemical warfare. Toxicity of nerve agents. Crit. Care Nurse 23 (2003) 15-20
28. Maxwell D.M., and Brecht K.M. The role of carboxylesterase in species variation of oxime protection against soman. Neurosci. Biobehav. Rev. 15 (1991) 135-139
29. Maxwell D.M., Brecht K.M., and O'Neill B.L. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol. Lett. 39 (1987) 35-42
30. Munro N. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection. Environ. Health Perspect. 102 (1994) 18-37
31. Nambiar M.P., Wright B.S., Smith K.B., Moran S.T., Richards S.M., Gordon R.K., and Sciuto A.M. Development of a microinstillation model of inhalation exposure to assess lung injury following exposure to toxic chemicals and nerve agents. Toxicol. Mech. Meth. 16 (2006) 295-300
32. Niven A.S., and Roop S.A. Inhalational exposure to nerve agents. Respir. Care Clin. N. Am. 10 (2004) 59-74
33. Sidell F.R. Chemical agent terrorism. Ann. Emerg. Med. 28 (1996) 223-224
34. Stenton G.R., Kim M.K., Nohara O., Chen C.F., Hirji N., Wills F.L., Gilchrist M., Hwang P.H., Park J.G., Finlay W., Jones R.L., Befus A.D., and Schreiber A.D. Aerosolized Syk antisense suppresses Syk expression, mediator release from macrophages, and pulmonary inflammation. J. Immunol. 164 (2000) 3790-3797
35. Stenton G.R., Ulanova M., Dery R.E., Merani S., Kim M.K., Gilchrist M., Puttagunta L., Musat-Marcu S., James D., Schreiber A.D., and Befus A.D. Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase. J. Immunol. 169 (2002) 1028-1036
36. Taysse L., Daulon S., Delamanche S., Bellier B., and Breton P. Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig. Toxicology 225 (2006) 25-35
37. Ulanova M., Puttagunta L., Kim M.K., Schreiber A.D., and Befus A.D. Antisense oligonucleotides to Syk kinase: a novel therapeutic approach for respiratory disorders. Curr. Opin. Investig. Drugs 4 (2003) 552-555
38. van Helden H.P., Kuijpers W.C., and Diemel R.V. Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 16 (2004) 537-548
39. Volans G.N., and Karalliedde L. Long-term effects of chemical weapons. Lancet 360 (2002) s35-s36 (Suppl.)
40. Wright B.S., Rezk P.E., Graham J.R., Steele K.E., Gordon R.K., Sciuto A.M., and Nambiar M.P. Acute lung injury following inhalation exposure to nerve agent VX in guinea pigs. Inhal. Toxicol. 18 (2006) 437-448